Trial Profile
A retrospective trial assessing the pathological effects of tamoxifen in patients with premenopausal breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2014
Price :
$35
*
At a glance
- Drugs Tamoxifen (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 13 Oct 2014 New trial record